Volume 9, Number 8—August 2003
Research
Invasive Group A Streptococcal Disease: Risk Factors for Adults
Stephanie H. Factor*†
, Orin S. Levine‡, Benjamin Schwartz*, Lee H. Harrison§, Monica M. Farley¶, Allison McGeer#, and Anne Schuchat*
, Orin S. Levine‡, Benjamin Schwartz*, Lee H. Harrison§, Monica M. Farley¶, Allison McGeer#, and Anne Schuchat*
Table 4
Individual risk factor and multivariable analysis for risk factors for invasive group A streptococcal disease case-patients and control subjects, matched by age group and zip code, 45+ years old, Atlanta, Baltimore, Toronto, 1997–1999a,b,c
| Variable | Univariate analysis | Multivariable analysis | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Case-patients
(n=91) |
Control subjects
(n=196) |
OR (95% CI) |
p value |
OR (95% CI) |
p value |
||||
| Number of
persons
living in
the home |
|||||||||
| 3+
1–2 |
47 (52)
44 (48) |
55 (28)
140 (72) |
2.64 (1.46 to 4.75) |
0.001 |
2.68 (1.37 to 5.28) |
0.004 |
|||
| Any child
living in
the home |
|||||||||
| Yes
No |
31 (34)
60 (66) |
33 (17)
163 (83) |
2.12 (1.11 to 4.05) |
0.02 |
|||||
| Smoke
exposure
Current
smoker
with passive
smoke
exposure |
|||||||||
| 15 (16) |
16 (8) |
2.37 (0.94 to 6.01) |
0.07 |
||||||
| Current
smoker
without
passive
smoke
exposure |
|||||||||
| 12 (13) |
32 (16) |
1.07 (0.49 to 2.33) |
0.86 |
||||||
| Passive
smoke
exposure |
|||||||||
| 19 (21) |
25 (13) |
2.34 (1.08, 5.04) |
0.03 |
||||||
| No smoke
exposure |
|||||||||
| 45 (49) |
123 (63) |
1.00 |
|||||||
| Diabetes
mellitus |
|||||||||
| Yes
No |
28 (31)
62 (69) |
32 (16)
164 (84) |
2.33 (1.22 to 4.45) |
0.01 |
2.27 (1.07 to 4.81) |
0.03 |
|||
| Hypertension |
|||||||||
| Yes
No |
47 (52)
42 (47) |
86 (45)
107 (55) |
1.61 (0.92 to 2.82) |
.10 |
|||||
| Cardiac disease |
|||||||||
| Yes
No |
30 (33)
60 (67) |
24 (12)
172 (88) |
3.09 (1.58, 6.06) |
0.001 |
3.24 (1.40 to 7.51) |
0.006 |
|||
| Chronic
obstructive
pulmonary
disease (COPD) |
|||||||||
| Yes
No |
8 (9)
79 (91) |
2 (1)
193 (99) |
7.85 (1.50 to 41.07) |
0.01 |
|||||
| Cancer |
|||||||||
| Yes
No |
18 (20)
71 (80) |
22 (11)
173 (89) |
2.58 (1.23 to 5.41) |
.01 |
3.54 (1.44 to 8.70) |
0.006 |
|||
| Varicella |
|||||||||
| Yes
No |
1 (1)
85 (99) |
0
191 (100) |
Undefined |
.99 |
|||||
| Cirrhosis |
|||||||||
| Yes
No |
5 (6)
82 (94) |
0
195 (100) |
Undefined |
0.99 |
|||||
| Paralysis |
|||||||||
| Yes
No |
5 (6)
84 (94) |
1 (1)
195 (99) |
11.61 (1.34 to 100.87) |
0.01 |
|||||
| Regular
NSAID
use |
|||||||||
| Yes
No |
43 (48)
46 (52) |
64 (34)
125 (66) |
1.82 (1.06 to 3.14) |
0.03 |
|||||
| New use of
NSAIDs |
|||||||||
| Yes
No |
14 (16)
72 (84) |
14 (7)
178 (93) |
2.13 (0.89 to 5.10) |
0.09 |
|||||
| Use of
cortico-
steroids |
|||||||||
| Yes
No |
9 (10)
77 (90) |
3 (2)
193 (98) |
4.96 (1.26 to 19.62) |
0.02 |
5.18 (1.14, 23.54) |
.03 |
|||
| HIV+ |
|||||||||
| Yes
No |
1 (1)
90 (99) |
2 (1)
194 (99) |
.51 (0.04 to 6.14) |
0.59 |
|||||
| Ever
injected
drugs |
|||||||||
| Yes
No |
6 (7)
78 (93) |
3 (2)
190 (98) |
5.48 (1.00 to 30.09) |
0.05 |
|||||
| Alcohol
use
based on
CAGE
questions |
|||||||||
| CAGE score 0 CAGE score 1 CAGE score 2 CAGE score 3 CAGE score 4 | 42 (78) 5 (9) 2 (4) 3 (6) 2 (4) | 107 (77) 19 (14) 9 (6 ) 4 (3) 0 | 0.95 (0.56 to 1.61) | .86 | |||||
aOR, odds ratio; CI, confidence interval; NSAID, nonsteroidal anti-inflammatory drug;
bDue to missing data, for some variables, data for fewer than 91 case-patients and 196 control subjects were available.
cAnalyses controlled for race and sex.
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.